Real-world drug usage survival of spironolactone versus oral antibiotics for the management of female patients with acne. Barbieri, J. S., Choi, J. K., James, W. D., & Margolis, D. J. Journal of the American Academy of Dermatology, 81(3):848–851, September, 2019. Number: 3
doi  bibtex   
@article{barbieri_real-world_2019,
	title = {Real-world drug usage survival of spironolactone versus oral antibiotics for the management of female patients with acne},
	volume = {81},
	doi = {S0190-9622(19)30452-9 [pii]},
	language = {eng},
	number = {3},
	journal = {Journal of the American Academy of Dermatology},
	author = {Barbieri, J. S. and Choi, J. K. and James, W. D. and Margolis, D. J.},
	month = sep,
	year = {2019},
	pmcid = {PMC6698210. DSI Core (C).},
	pmid = {30905798},
	note = {Number: 3},
	keywords = {DSI Core},
	pages = {848--851},
}

Downloads: 0